Category: pain
-
Trump’s marijuana reclassification could boost research, broaden access
Trump’s marijuana reclassification could boost research, broaden access President Trump on Thursday signed an executive order directing the federal government to reclassify marijuana as a Schedule III substance, marking a major milestone in American drug policy and choosing sides in the debate between advocates for more research and drug policy hawks. Under the new classification,…
-
Closing a zombie biotech, and Lilly’s disappointing obesity readout
Closing a zombie biotech, and Lilly’s disappointing obesity readout How does a biotech company decide to shut itself down? Why does Eli Lilly have so much riding on its oral obesity candidate? And what’s the outlook for Vertex’s pain franchise? We discuss that and more on this on this week’s episode of “The Readout LOUD,”…
-
STAT+: Vertex next-generation pain candidate fails Phase 2 trial
STAT+: Vertex next-generation pain candidate fails Phase 2 trial Vertex Pharmaceuticals said Monday afternoon that its next-generation non-opioid pain reliever failed to significantly outperform placebo in a Phase 2 trial. The experimental drug, codenamed VX-993, is similar to the company’s recently approved pill Journavx but could potentially be given at higher doses and formulated as…